Pfizer Can't Shake Securities Action Over Celebrex Risks

By Matt Chiappardi (March 29, 2013, 5:23 PM EDT) -- A New York federal judge on Thursday trimmed a long-running securities class action accusing Pfizer Inc. of concealing serious health risks associated with blockbuster painkillers Celebrex and Bextra, but ruled the bulk of the plaintiff's allegations were strong enough to advance....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!